Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Shanghai OPM Biosciences Revenue

Shanghai OPM Biosciences had revenue of 182.16M CNY in the quarter ending March 31, 2026, with 117.68% growth. This brings the company's revenue in the last twelve months to 453.39M, up 50.52% year-over-year. In the year 2025, Shanghai OPM Biosciences had annual revenue of 354.91M with 19.40% growth.

• Revenue (ttm): 453.39M
• Revenue Growth: +50.52%
• P/S Ratio: 15.99
• Revenue / Employee: 1.38M
• Employees: 64
• Market Cap: 7.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	354.91M	57.67M	19.40%
Dec 31, 2024	297.24M	54.12M	22.26%
Dec 31, 2023	243.12M	-51.24M	-17.41%
Dec 31, 2022	294.37M	81.68M	38.41%
Dec 31, 2021	212.68M	87.71M	70.19%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error